CIK 0000897448 · Accelerated filer
AMARIN CORP PLCUK
Sign in to watch- Ticker
- AMRN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- United Kingdom
- Entity type
- operating
- Phone
- 353 1 6699 020
- Business address
- SPACES SOUTH DOCKLANDS, BLOCK C, 77 SIR JOHN ROGERSON'S QUAY, DUBLIN 2, Ireland
- Former names
- AMARIN CORP PLC\UK, AMARIN PHARMACEUTICALS PLC, ETHICAL HOLDINGS PLC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-01-30 | Berg Aaron President and CEO | Option exercise · Restricted Stock Unit | −51,500 | 0 | ||
| 2025-01-10 | Ketchum Steven B Chief Scientific Officer | Grant or award · Stock Option (right to buy) | +663,878 | 663,878 | ||
| 2025-01-10 | Fishman Peter L. SVP, CFO | Grant or award · Stock Option (Right to Buy) | +440,475 | 440,475 | ||
| 2025-01-10 | Provoost Jonathan EVP, Chief Legal Officer | Grant or award · Stock Option (Right to Buy) | +663,878 | 663,878 | ||
| 2024-08-02 | Berg Aaron President and CEO | Purchase | +160,000 | $0.64 | $102K | 805,380 |
| 2024-08-01 | Berg Aaron President and CEO | Grant or award · Stock Option (right to buy) | +5,000,000 | 5,000,000 | ||
| 2024-07-31 | Ketchum Steven B Chief Scientific Officer | Option exercise | +23,883 | 682,603 | ||
| 2024-07-31 | Ketchum Steven B Chief Scientific Officer | Shares withheld for taxes | −11,763 | $0.78 | $9K | 670,840 |
| 2024-07-31 | Berg Aaron President and CEO | Option exercise | +23,883 | 657,143 | ||
| 2024-07-31 | Berg Aaron President and CEO | Shares withheld for taxes | −11,763 | $0.78 | $9K | 645,380 |
| 2024-07-01 | Reilly Thomas Charles EVP and CFO | Option exercise | +16,667 | 102,514 | ||
| 2024-07-01 | Reilly Thomas Charles EVP and CFO | Shares withheld for taxes | −8,209 | $0.69 | $6K | 94,305 |
| 2024-07-01 | Reilly Thomas Charles EVP and CFO | Option exercise · Restricted Stock Unit | −16,667 | 16,666 | ||
| 2024-06-20 | Reilly Thomas Charles EVP and CFO | Option exercise | +33,333 | 102,264 | ||
| 2024-06-20 | Reilly Thomas Charles EVP and CFO | Shares withheld for taxes | −16,417 | $0.73 | $12K | 85,847 |
| 2024-06-20 | Reilly Thomas Charles EVP and CFO | Option exercise · Restricted Stock Unit | −33,333 | 33,333 | ||
| 2024-04-18 | Cohen Paul Director | Grant or award · Stock Option (right to buy) | +179,795 | 179,795 | ||
| 2024-04-18 | Cohen Paul Director | Grant or award · Restricted Stock Unit | +50,287 | 50,287 | ||
| 2024-04-18 | Sullivan Diane E. Director | Grant or award · Stock Option (right to buy) | +179,795 | 179,795 | ||
| 2024-04-18 | Sullivan Diane E. Director | Grant or award · Restricted Stock Unit | +50,287 | 50,287 |
Page 9 of 67 · 1,339 trades